These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7704084

  • 1. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
    Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Haji M, Umeda F, Nawata H.
    Endocr J; 1994 Dec; 41(6):605-11. PubMed ID: 7704084
    [Abstract] [Full Text] [Related]

  • 2. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
    Mazière C, Auclair M, Ronveaux MF, Salmon S, Santus R, Mazière JC.
    Atherosclerosis; 1991 Aug; 89(2-3):175-82. PubMed ID: 1793445
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol.
    Rifici VA, Khachadurian AK.
    Metabolism; 1992 Oct; 41(10):1110-4. PubMed ID: 1328822
    [Abstract] [Full Text] [Related]

  • 4. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E, Furman C, Fouquet S, Martin-Nizard F, Lestavel S, Gozzo A, Lesieur D, Fruchart JC, Duriez P, Teissier E.
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of high-density lipoprotein subfractions inhibiting copper-catalyzed oxidation of low-density lipoprotein.
    Huang JM, Huang ZX, Zhu W.
    Clin Biochem; 1998 Oct; 31(7):537-43. PubMed ID: 9812173
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids.
    Rattan AK, Arad Y.
    Atherosclerosis; 1998 Feb; 136(2):305-14. PubMed ID: 9543102
    [Abstract] [Full Text] [Related]

  • 7. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation.
    Tang M, Abplanalp W, Ayres S, Subbiah MT.
    Metabolism; 1996 Apr; 45(4):411-4. PubMed ID: 8609824
    [Abstract] [Full Text] [Related]

  • 8. Effect of estradiol metabolites on the susceptibility of low density lipoprotein to oxidation.
    Seeger H, Mueck AO, Lippert TH.
    Life Sci; 1997 Apr; 61(9):865-8. PubMed ID: 9284079
    [Abstract] [Full Text] [Related]

  • 9. In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins.
    Martín C, Barturen K, Martínez R, Lacort M, Ruiz-Larrea MB.
    J Physiol Biochem; 1998 Dec; 54(4):195-202. PubMed ID: 10225411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Magnoflorine from Coptidis Rhizoma protects high density lipoprotein during oxidant stress.
    Hung TM, Lee JP, Min BS, Choi JS, Na M, Zhang X, Ngoc TM, Lee I, Bae K.
    Biol Pharm Bull; 2007 Jun; 30(6):1157-60. PubMed ID: 17541173
    [Abstract] [Full Text] [Related]

  • 12. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L.
    Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
    [Abstract] [Full Text] [Related]

  • 13. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B, Volkova N, Rosenblat M, Aviram M.
    Antioxid Redox Signal; 2000 Aug; 2(3):491-506. PubMed ID: 11229363
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation.
    Khalil A, Fortin JP, LeHoux JG, Fülöp T.
    J Lipid Res; 2000 Oct; 41(10):1552-61. PubMed ID: 11013296
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide released from zwitterionic polyamine/NO adducts inhibits Cu2+-induced low density lipoprotein oxidation.
    Yamanaka N, Oda O, Nagao S.
    FEBS Lett; 1996 Nov 25; 398(1):53-6. PubMed ID: 8946952
    [Abstract] [Full Text] [Related]

  • 20. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS.
    Atherosclerosis; 1998 Jun 25; 138(2):271-80. PubMed ID: 9690910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.